Investigation of bioequivalence - Scientific guideline
Submitted by Anonymous (not verified) on 26 February 2025 - 11:58
Investigation of bioequivalence - Scientific guideline
ICH Guideline M13A on bioequivalence for immediate-release solid oral dosage forms - Scientific guideline
Submitted by Anonymous (not verified) on 26 February 2025 - 11:58
ICH Guideline M13A on bioequivalence for immediate-release solid oral dosage forms - Scientific guideline
Clinical evaluation of new vaccines - Scientific guideline
Submitted by Anonymous (not verified) on 26 February 2025 - 10:44
Clinical evaluation of new vaccines - Scientific guideline
Human medicines European public assessment report (EPAR): Giotrif, afatinib, Date of authorisation: 25/09/2013, Revision: 16, Status: Authorised
Submitted by Anonymous (not verified) on 26 February 2025 - 9:45
Human medicines European public assessment report (EPAR): Giotrif, afatinib, Date of authorisation: 25/09/2013, Revision: 16, Status: Authorised
Addendum to the Guideline on clinical development of vaccines to address clinical trials in immunocompromised individuals
Submitted by Anonymous (not verified) on 26 February 2025 - 9:16
Addendum to the Guideline on clinical development of vaccines to address clinical trials in immunocompromised individuals
Agenda - PDCO agenda of the 25-28 February 2025 meeting
Submitted by Anonymous (not verified) on 26 February 2025 - 9:08
Agenda - PDCO agenda of the 25-28 February 2025 meeting
EMEA-003063-PIP02-22
Submitted by Anonymous (not verified) on 26 February 2025 - 8:17
EMEA-003063-PIP02-22
EMEA-000786-PIP01-09-M02
Submitted by Anonymous (not verified) on 26 February 2025 - 8:08
EMEA-000786-PIP01-09-M02
Medicinal products for human use: monthly figures - January 2025
Submitted by Anonymous (not verified) on 25 February 2025 - 15:22
Medicinal products for human use: monthly figures - January 2025
CTIS newsflash - 25 February 2025
Submitted by Anonymous (not verified) on 25 February 2025 - 15:09
CTIS newsflash - 25 February 2025